Building Your Care Team: Therapies and Treatments
At a Glance
While there is no cure for Fragile X syndrome, a multidisciplinary approach combining occupational, speech, and behavioral therapies with symptom-management medications is highly effective. A robust care team includes developmental pediatricians, therapists, and specialized medical providers.
While there is currently no “cure” that fixes the underlying FMR1 gene, the standard of care for Fragile X Syndrome (FXS) is robust and effective. It focuses on a multidisciplinary approach—treating the symptoms to improve your child’s independence, communication, and quality of life [1][2]. The most successful plans combine therapeutic interventions with carefully monitored medical care [3][4].
The Foundation: Non-Pharmacological Therapies
Therapy is the first line of management for FXS. These interventions help the brain find new ways to process information and interact with the world [1][5].
- Occupational Therapy (OT): Focuses on sensory processing and fine motor skills. OT is vital for helping children manage sensory hyperarousal (feeling overwhelmed by noise or touch) [1][4].
- Speech-Language Therapy: Addresses delays in expressive and receptive language. Many families also use Augmentative and Alternative Communication (AAC) tools, like picture boards or tablets, to help children express themselves [6][3].
- Behavioral Therapy: Function-based interventions (such as ABA) are highly effective for reducing challenging behaviors or behaviors that interfere with safety (like aggression or self-injury) by teaching alternative ways to communicate needs [7][8].
- Physical Therapy (PT): Helps with “gross motor” skills, such as walking and balance, which can be affected by low muscle tone or flexible joints [1].
The Care Team Roster
Managing FXS requires a “team” of experts working together. You may want to include the following specialists in your child’s circle [2][3][4]:
- Developmental Pediatrician: Often the “quarterback” of the team, overseeing overall growth and development.
- Geneticist/Genetic Counselor: For initial diagnosis and to help family members understand their own risks.
- Neurologist: Specifically if your child experiences seizures (common in about 15% of males with FXS).
- Child Psychiatrist: To manage medications for anxiety, ADHD, or mood.
- Special Education Team: To create an IEP (Individualized Education Program) tailored to how children with FXS learn.
Medications: Treating the Symptoms
There is no “Fragile X pill,” so doctors use “off-label” medications—drugs approved for other conditions that are known to help with FXS symptoms [9][5].
- For Anxiety: SSRIs (Selective Serotonin Reuptake Inhibitors) like sertraline (Zoloft) are the most common [9][1].
- For ADHD: Stimulants (like methylphenidate) or alpha-agonists (like clonidine or guanfacine) help with hyperactivity and focus [9][10].
- For Aggression/Irritability: These are not first-line treatments for young children. If behaviors like aggression or self-injury become severe in older children or teens, “atypical antipsychotics” like aripiprazole (Abilify) or risperidone (Risperdal) may be considered [9][5]. Important Note: These medications carry high risks for metabolic syndrome, including substantial weight gain and increased diabetes risk. They require active monitoring of your child’s diet and regular pediatric lab work [9].
The Future: Targeted Therapies
Researchers are working on “targeted therapies”—drugs designed to fix the specific chemical imbalances in the Fragile X brain [11][12].
- PDE4D Inhibitors (Zatolmilast): This is one of the most promising areas of current research. In Phase 2 clinical trials, this medication (also known as BPN14770) showed potential for improving cognitive performance and daily functioning in males with FXS [11][13].
- Other Trials: Research continues into GABA modulators, metformin, and even CBD, though these are not yet standard treatments [1][14].
Participating in a clinical trial is a personal family decision and an opportunity to contribute to the future of Fragile X care [15].
Common questions in this guide
What are the best therapies for a child with Fragile X syndrome?
Are there medications that cure Fragile X syndrome?
What kind of doctors should be on my child's Fragile X care team?
How does occupational therapy help with Fragile X syndrome?
What is Zatolmilast and how does it treat Fragile X?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you help us prioritize which therapy (Speech, OT, or Behavioral) my child needs most right now to see the best progress?
- 2.Which 'off-label' medications do you have the most experience using for anxiety or ADHD in children with Fragile X?
- 3.Is there a Fragile X Clinic or a developmental specialist in our area who can serve as the 'hub' for our multidisciplinary team?
- 4.What are the specific side effects we should watch for if we start a medication like sertraline or a stimulant?
- 5.Are there any active clinical trials, such as those for PDE4D inhibitors, that my child might be eligible for?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
State-of-the-art therapies for fragile X syndrome.
Protic D, Hagerman R
Developmental medicine and child neurology 2024; (66(7)):863-871 doi:10.1111/dmcn.15885.
PMID: 38385885 - 2
New Therapeutic Options for Fragile X Syndrome.
Jalnapurkar I, Cochran DM, Frazier JA
Current treatment options in neurology 2019; (21(3)):12 doi:10.1007/s11940-019-0551-8.
PMID: 30809735 - 3
Fragile X syndrome: genetic and clinical profile in the Hong Kong Chinese population.
Au CWM, Luk HM, Ho S, et al.
Hong Kong medical journal = Xianggang yi xue za zhi 2025; (31(3)):199-207 doi:10.12809/hkmj2411942.
PMID: 40468528 - 4
Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India.
Sachdeva A, Jain P, Gunasekaran V, et al.
Indian pediatrics 2019; (56(3)):221-228.
PMID: 30954995 - 5
Behavioural difficulties in fragile X syndrome: current pharmacological options and potential future developments.
Stanfield AC, McKechanie AG
Expert review of neurotherapeutics 2025; (25(7)):857-867 doi:10.1080/14737175.2025.2510408.
PMID: 40462554 - 6
Parent Perspectives on Augmentative and Alternative Communication Integration for Children With Fragile X Syndrome: It Starts in the Home.
Schladant M, Dowling M
Intellectual and developmental disabilities 2020; (58(5)):409-421 doi:10.1352/1934-9556-58.5.409.
PMID: 33032315 - 7
Functional analysis and treatment of problem behavior exhibited by children with fragile X syndrome.
Kurtz PF, Chin MD, Robinson AN, et al.
Research in developmental disabilities 2015; (43-44()):150-66.
PMID: 26183339 - 8
Conducting In-Home Functional Analyses of Aggression and Self-Injury Exhibited by Boys with Fragile X Syndrome.
Monlux KD, Pollard JS, Bujanda Rodriguez AY, Hall SS
Journal of developmental and behavioral pediatrics : JDBP 2022; (43(4)):e237-e245 doi:10.1097/DBP.0000000000001019.
PMID: 34711767 - 9
Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
Dominick KC, Andrews HF, Kaufmann WE, et al.
Journal of child and adolescent psychopharmacology 2021; (31(10)):659-669 doi:10.1089/cap.2021.0042.
PMID: 34818076 - 10
Effects of clonidine on progressive ratio schedule performance in Fmr1 knockout mice.
Wrenn CC, French E, Baker D, et al.
Psychopharmacology 2021; (238(4)):1133-1140 doi:10.1007/s00213-021-05760-8.
PMID: 33449137 - 11
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
Berry-Kravis EM, Harnett MD, Reines SA, et al.
Nature medicine 2021; (27(5)):862-870 doi:10.1038/s41591-021-01321-w.
PMID: 33927413 - 12
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder.
Thomas SD, Mohammed HA, Hamad MIK, et al.
Pharmaceuticals (Basel, Switzerland) 2025; (18(10)) doi:10.3390/ph18101507.
PMID: 41155624 - 13
ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers.
Norris JE, Berry-Kravis EM, Harnett MD, et al.
Translational psychiatry 2025; (15(1)):323 doi:10.1038/s41398-025-03558-2.
PMID: 40877251 - 14
Dietary fish oil improves autistic behaviors and gut homeostasis by altering the gut microbial composition in a mouse model of fragile X syndrome.
Guo P, Yang X, Guo X, et al.
Brain, behavior, and immunity 2023; (110()):140-151 doi:10.1016/j.bbi.2023.02.019.
PMID: 36858183 - 15
Emerging autism and Fragile X syndrome treatments.
Parkhill M, Salmaso N, D'Angiulli A, et al.
Trends in pharmacological sciences 2025; (46(4)):357-371 doi:10.1016/j.tips.2025.02.004.
PMID: 40102109
This page provides educational information about Fragile X syndrome treatments and therapies. It is not a substitute for professional medical advice, diagnosis, or treatment for your child.
Get notified when new evidence is published on Fragile X syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.